Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC

PHASE3RecruitingINTERVENTIONAL
Enrollment

190

Participants

Timeline

Start Date

March 12, 2018

Primary Completion Date

June 30, 2026

Study Completion Date

September 30, 2026

Conditions
Locally Advanced Pancreatic Cancer
Interventions
DRUG

Gemcitabine

Chemotherapy

DRUG

nab-paclitaxel

Chemotherapy

DEVICE

RenovoCath

Intra-arterial catheter

Trial Locations (42)

2650

TERMINATED

UZ Antwerp, Edegem

7100

TERMINATED

Jolimont Hospital, La Louvière

8310

TERMINATED

AZ Sint-Lucas, Bruges

8800

TERMINATED

AZ Delta, Roeselare

9000

TERMINATED

AZ Maria Middelares, Ghent

WITHDRAWN

UZ Gent, Ghent

10032

ACTIVE_NOT_RECRUITING

Columbia University Medical Center, New York

10461

TERMINATED

Montefiore Hospital, The Bronx

11030

RECRUITING

Feinstein Institutes for Medical Research - Northwell Health, Manhasset

12208

WITHDRAWN

Albany Stratton VA Medical Center, Albany

15232

RECRUITING

University of Pittsburgh Medical Center, Pittsburgh

20016

RECRUITING

Sibley Memorial Hospital - a member of Johns Hopkins medicine, Washington D.C.

20057

WITHDRAWN

Georgetown University, Washington D.C.

21237

TERMINATED

Medstar Franklin Square, Baltimore

26506

RECRUITING

West Virginia University Medicine, Morgantown

27157

ACTIVE_NOT_RECRUITING

Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem

27834

RECRUITING

East Carolina University, Greenville

28204

RECRUITING

Levine Cancer Institute - Atrium Health, Charlotte

29425

ACTIVE_NOT_RECRUITING

Medical University of South Carolina - Hollings Cancer Center, Charleston

29605

RECRUITING

Prisma Health (formerly Greenville Health System), Greenville

31904

WITHDRAWN

Piedmont-Columbus Regional - John B. Amos Cancer Center, Columbus

33167

RECRUITING

Miami Cancer Center, Miami

33612

TERMINATED

Moffitt Cancer Center, Tampa

33907

TERMINATED

21st Century Oncology, Fort Myers

34329

RECRUITING

Sarasota Memorial Health Care System, Sarasota

34607

TERMINATED

ASCLEPES Research Centers, Weeki Wachee

37203

RECRUITING

Sarah Cannon Research Institute, Nashville

52242

RECRUITING

University of Iowa Hospitals and Clinics - Holden Comprehensive Cancer Center, Iowa City

68198

RECRUITING

University of Nebraska Medical Center, Omaha

70121

WITHDRAWN

Ochsner Clinic Foundation, New Orleans

71103

WITHDRAWN

LSU Health Shreveport, Shreveport

73104

RECRUITING

Oklahoma University - Stephenson Cancer Center, Oklahoma City

75390

RECRUITING

University of Texas Southwestern Medical Center, Dallas

80113

WITHDRAWN

Comprehensive Cancer Care and Research Institute of Colorado, CCCRIC, Englewood

80218

WITHDRAWN

Rocky Mountain Cancer Centers, Denver

92357

TERMINATED

VA Loma Linda Healthcare System, Loma Linda

95816

RECRUITING

Sutter Cancer Center Sacramento, Sacramento

97239

RECRUITING

Oregon Health & Science University, Portland

98108

WITHDRAWN

VA Puget Sound Health Care System, Seattle

03766

TERMINATED

Dartmouth-Hitchcock Medical Center, Lebanon

08103

TERMINATED

MD Anderson Cancer Center at Cooper Hospital, Camden

07960

WITHDRAWN

Atlantic Health System - Morristown Medical Center, Morristown

Sponsors

Lead Sponsor

All Listed Sponsors
lead

RenovoRx

INDUSTRY

NCT03257033 - Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC | Biotech Hunter | Biotech Hunter